Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Twist Bioscience
Twist Bioscience
Activities:
Research & Development
Pharmaceutical
Trending Articles
RCPE and InSilicoTrials to digitalise and accelerate the development of pharmaceutical manufacturing processes
RCPE and InSilicoTrials have agreed to an exclusive partnership to commercialise the XPS simulation software. Specifically developed for pharmaceutical applications, XPS allows...
Pace Life Sciences expands US aseptic fill-finish manufacturing site
The facility in Salem, New Hampshire is now better equipped to deal with small-batch cGMP injectable manufacturing for clinical-stage clients
HeartBeat.bio and biotix.ai join forces to identify heart failure targets
The collaboration will aim to uncover new genetic targets for treating heart failure — one of the leading causes of death globally
Ingenza appoints Nick Challoner as Chief Executive Officer
Nick brings over 30 years of experience in business leadership, innovation, and commercial strategy and execution across the chemical and biotechnology sectors
Pharmaseal and Viedoc partner to streamline the clinical trial management process
By combining technologies, the companies hope to help CROs conduct efficient and compliant global clinical trials
Upcoming event
POWTECH
23-25 September 2025 | Exhibition | Nuremberg, Germany
See all
Related Content
Pharmaceutical
Twist Bioscience puts antibody optimisation potential to use
Partnership to apply antibody optimisation platform to the targeting arm of a bispecific antibody
Manufacturing
Twist Bioscience and LakePharma share resources for antibody platform
Twist will provide its antibody discovery platform, LakePharma will provide development services
Manufacturing
Automated microfluidics for gene editing is in the works
Oxford Genetics has announced a partnership to optimise the way laboratories deliver gene editing to cells and interrogate the resultant products
Research & Development
Leaders of transformation
Haig Armaghanian, founder and CEO of Haig Barrett, explores how synthetic biology pioneers are revolutionising therapeutic development
Subscribe now